290: Biotech layoffs, slumping stocks, and a 2024 preview

Our colleague Jason Mast joins us to discuss an emerging trend in biotech: Cash-rich startups are laying off employees and tweaking their strategies amid a tough market for venture capital. We also look ahead to the biggest biotech stories coming in 2024, including some major data readouts and a few pivotal FDA decisions. Here's where you can subscribe to our biotech newsletter, The Readout.

Episode metadata supplied by the publisher feed · Published Jan 18, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

290: Biotech layoffs, slumping stocks, and a 2024 preview

0:00 42:49

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Readout Loud?

This episode is 42 minutes long.

When was this The Readout Loud episode published?

This episode was published on January 18, 2024.

Can I download this The Readout Loud episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!